.; .
.
Lurasidone is an atypical antipsychotic approved in 2010 in Canada and in the USA for the treatment of adults with schizophrenia or bipolar type I disorder. In 2014 it was approved in the European Union for the treatment of patients with 13 years‑old or older, with schizophrenia. Lurasidone is a benzisothiazole derivative with a binding profile that makes it an antidepressant candidate with a low metabolic impa...
Forensic Telepsychiatry has had growing usage in countries such as the USA and England in the last decade, due to ongoing development of technologies which allow a better access to mental health care in needed populations, and improve the outcome of technicians' work, while facing a more demanding performance of Mental Health facilities. In this article we make a revision of literature concerning applications o...
O síndrome serotoninérgico é uma entidade clínica relativamente infrequente, mas que pode ter consequências potencialmente letais. O espectro de manifestações é altamente variável, desde discreto tremor e diarreia a alterações do estado mental, hiperactividade autonómica, hipertermia e contracções clóricas. Oitenta e cinco por cento dos médicos não estão familiarizados com as características do síndrome. Preten...